Australia Bronchial Biopsy Devices Market Size & Outlook

The bronchial biopsy devices market in Australia is expected to reach a projected revenue of US$ 33.2 million by 2030. A compound annual growth rate of 7.7% is expected of Australia bronchial biopsy devices market from 2025 to 2030.
Revenue, 2024 (US$M)
$21.2
Forecast, 2030 (US$M)
$33.2
CAGR, 2025 - 2030
7.8%
Report Coverage
Australia

Australia bronchial biopsy devices market, 2018-2030 (US$M)

Australia

Australia bronchial biopsy devices market highlights

  • The Australia bronchial biopsy devices market generated a revenue of USD 18.9 million in 2023 and is expected to reach USD 31.5 million by 2030.
  • The Australia market is expected to grow at a CAGR of 7.6% from 2024 to 2030.
  • In terms of segment, transbronchial needle aspiration (tbna) needles was the largest revenue generating product in 2023.
  • Transbronchial Needle Aspiration (TBNA) Needles is the most lucrative product segment registering the fastest growth during the forecast period.


Bronchial biopsy devices market data book summary

Market revenue in 2023USD 18.9 million
Market revenue in 2030USD 31.5 million
Growth rate7.6% (CAGR from 2023 to 2030)
Largest segmentTransbronchial needle aspiration (tbna) needles
Fastest growing segmentTransbronchial Needle Aspiration (TBNA) Needles
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBiopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes
Key market players worldwideOlympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International


Other key industry trends

  • In terms of revenue, Australia accounted for 3.2% of the global bronchial biopsy devices market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China bronchial biopsy devices market is projected to lead the regional market in terms of revenue in 2030.
  • Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 42.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Bronchial Biopsy Devices Market Companies

Name Profile # Employees HQ Website

Australia bronchial biopsy devices market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.


Transbronchial needle aspiration (tbna) needles was the largest segment with a revenue share of 65.08% in 2024. Horizon Databook has segmented the Australia bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.


Australia is recognized for its advanced healthcare system, bolstered by the public and private sectors. The government’s emphasis on enhancing healthcare delivery and integrating technology is expected to drive the development and adoption of advanced diagnostic tools, including bronchial biopsy devices.

In Australia, the adoption of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration (EBUS-TBNA) is increasingly recognized for its effectiveness in diagnosing lung cancer and other respiratory conditions. This minimally invasive technique allows for the sampling of mediastinal lymph nodes, providing critical information for staging lung cancer and evaluating other thoracic diseases.

A notable study conducted across 4 Australian tertiary referral centers highlighted the utility of EBUS-TBNA in diagnosing mediastinal tuberculous lymphadenitis. The study demonstrated that EBUS-TBNA is effective and has a high diagnostic accuracy for various conditions, including lung cancer.

Reasons to subscribe to Australia bronchial biopsy devices market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia bronchial biopsy devices market databook

  • Our clientele includes a mix of bronchial biopsy devices market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia bronchial biopsy devices market , including forecasts for subscribers. This country databook contains high-level insights into Australia bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia bronchial biopsy devices market size, by product, 2018-2030 (US$M)

Australia Bronchial Biopsy Devices Market Outlook Share, 2024 & 2030 (US$M)

Australia bronchial biopsy devices market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more